4//SEC Filing
Bruno Lawrence 4
Accession 0001209191-23-001001
CIK 0001000229other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:46 PM ET
Size
8.5 KB
Accession
0001209191-23-001001
Insider Transaction Report
Form 4
Bruno Lawrence
President
Transactions
- Tax Payment
Common Shares
2022-12-31$20.27/sh−35,892$727,531→ 102,518 total - Exercise/Conversion
Performance Shares
2022-12-31−91,212→ 0 totalExercise: $0.00→ Common Shares (91,212 underlying) - Exercise/Conversion
Common Shares
2022-12-31+91,212→ 138,410 total
Footnotes (1)
- [F1]These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001730336
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:46 PM ET
- Size
- 8.5 KB